S.L. 458.35 · Pharmacovigilance Regulations (S.L. 458.35)
S.L. 458.35 ст. 23Report follow-up.
For reports submitted by a marketing authorisation holder, where the suspected adverse reaction occurred in Malta, the Authority may involve the marketing authorisation holder in the follow-up of the reports.